ALNYLAM PHARMACEUTICALS, INC. (ALNY) Revenue 2016–2025
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.7BFY2025 · since FY2016: $47.2M → $3.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.7B | +65.2% |
| FY2024 | $2.2B | +23.0% |
| FY2023 | $1.8B | +76.2% |
| FY2022 | $1.0B | +22.9% |
| FY2021 | $844.3M | +71.3% |
| FY2020 | $492.9M | +124.3% |
| FY2019 | $219.8M | +193.4% |
| FY2018 | $74.9M | -16.7% |
| FY2017 | $89.9M | +90.7% |
| FY2016 | $47.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice